Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • Bitcoin USD

    64,375.40
    +1,076.10 (+1.70%)
     

  • CMC Crypto 200

    1,382.83
    +70.21 (+5.35%)
     

  • S&P 500

    4,965.42
    -45.70 (-0.91%)
     

  • Dow

    37,949.32
    +173.94 (+0.46%)
     

  • Nasdaq

    15,279.06
    -322.44 (-2.07%)
     

  • Gold

    2,409.20
    +11.20 (+0.47%)
     

  • Crude Oil

    83.30
    +0.57 (+0.69%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Here’s What Eli Lilly’s Latest Clinical Win Means For Investors

Prosper Junior Bakiny, The Motley Fool
·4-min read
Here’s What Eli Lilly’s Latest Clinical Win Means For Investors

Few pharmaceutical giants have performed as well or better than Eli Lilly (NYSE: LLY) in the stock market over the past year. The Indianapolis-based company's secret wasn't its financial results, as they were relatively mild, or even downright disappointing, for much of this period. The market is forward-looking, and with the drugmaker producing several highly promising programs, investors are increasingly excited regarding Eli Lilly's future.

Continue reading